Pharmacologic Therapies for Obesity: The Future is Here Mayo Clinic Cardiovascular CME

Pharmacologic Therapies for Obesity: The Future is Here
 
Guest: Kyla M. Lara-Breitinger, M.D.
Hosts: Sharonne N. Hayes, M.D.
Join us in this expert podcast as we delve into the captivating world of GLP-1 receptor agonists (GLP-1RAs), exploring their profound impact on weight management and cardiometabolic effects.  We also discuss the potential cardiovascular benefits affecting patients with obesity and cardiovascular disease.
Topics Discussed:

The popularity of the GLP-1RAs


Short-term and long-term benefits and consequences


Cardiovascular benefits with taking these medications

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.